Save this content for laterSave this content on your device for later, even while offline Sign in with FacebookSign in with your Facebook account Close

More Movers-and-shakers Articles

MED-Pfizer-Cancer Drug
FILE - In this Monday, Nov. 23, 2015, file photo, a Pfizer flag is displayed in front of the company's world headquarters in New York. The Food and Drug Administration has approved a new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed. Pfizer’s Besponsa was approved for patients with a type of advanced acute lymphoblastic leukemia. (AP Photo/Mark Lennihan, File)
EpiPen-Mylan Overcharges
FILE - This Oct. 10, 2013, file photo, shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. Mylan has finalized a $465 million federal agreement settling allegations it overbilled Medicaid for its emergency allergy injectors for a decade, charges brought after rival Sanofi filed a whistleblower lawsuit and tipped off the government. (AP Photo/Mark Zaleski, File)
Overdoses Car Crashes
In this Aug. 9, 2017, photo, Koriann Evans, a former drug addict, holds up a photo of herself with an anti-addiction message written on her hand at her home in Bellevue, Ohio. Evans was hooked on heroin for over a decade until she overdosed while driving her car with her two children in the back, after which she stopped using drugs and started speaking about her former addiction. Police and rescue crews say drivers overdosing on heroin and other drugs are driving up the number of car crashes. (AP Photo/Dake Kang)
Science Says Reacting to DNA
National Institutes of Health (NIH) Director Francis Collins poses for a portrait at the NIH headquarters in Bethesda, Md., Friday, July 28, 2017. After DNA testing showed he was predisposed to Type 2 diabetes, which is more likely to develop if a person is overweight or obese, Collins shed 35 pounds (16 kilograms). (AP Photo/Sait Serkan Gurbuz)